Medtronic to buy up to $90M stake in heart valve developer Anteris

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

By Susan Kelly • Jan. 21, 2026

BVI appoints Jim Hollingshead as CEO

Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.

By Nick Paul Taylor • Jan. 21, 2026

Explore the Trendline➔

Top 5 stories from MedTech Dive

From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

Abbott gets Europe’s CE mark for dual ablation catheter

The device can deliver both radiofrequency energy and pulsed field ablation to treat heart arrhythmias.

By Elise Reuter • Jan. 20, 2026

3 takeaways from Boston Scientific’s $14.5B Penumbra deal

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between the two companies’ products.

By Elise Reuter • Jan. 20, 2026

Boston Scientific recalls stent over issue linked to 3 deaths

The company said the deaths were associated with off-label or investigational use of the device.

By Nick Paul Taylor • Jan. 20, 2026

Intuitive says general surgery, acute care fuel US robot momentum

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.

By Susan Kelly • Jan. 16, 2026

STAAR CEO exits after company rejects Alcon buyout

An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.

By Nick Paul Taylor • Jan. 16, 2026

Trump issues 25% tariffs on narrow range of semiconductors

The levies, effective Jan. 15, do not cover products used for data centers and consumer applications, per a proclamation signed Wednesday.

By Antone Gonsalves , Phil Neuffer • Jan. 15, 2026

Boston Scientific to acquire Penumbra for $14.5B

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

By Elise Reuter • Jan. 15, 2026

Medtronic inks deal to build brain computer interface into surgical system

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation system.

By Nick Paul Taylor • Jan. 15, 2026

5 topics to watch as MDUFA negotiations restart

The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a five-year period, are expected to go to Congress this year.

By Elise Reuter • Jan. 14, 2026

Boston Scientific gains FDA’s OK for new PFA catheter

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.

By Susan Kelly • Jan. 14, 2026

Smith & Nephew to acquire Integrity Orthopaedics for up to $450M

The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff repair system.

By Nick Paul Taylor • Jan. 14, 2026

Medtronic gets FDA clearance for smart insulin pen app

The app pairs Medtronic’s smart insulin pens with a sensor made by Abbott.

By Elise Reuter • Jan. 13, 2026

Inspire appoints Matt Osberg as CFO

While Osberg joins Inspire without prior medtech experience, CEO Tim Herbert says the new CFO can help take the company “to the next level.”

By Nick Paul Taylor • Jan. 13, 2026

Boston Scientific to buy incontinence device maker Valencia

The deal would set up Boston Scientific to compete with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.

By Susan Kelly • Jan. 12, 2026

Edwards calls off JenaValve buyout after court halts deal

Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns.

By Susan Kelly • Jan. 12, 2026

Haemonetics to acquire Vivasure Medical

The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.

By Elise Reuter • Jan. 9, 2026

CMR robot earns CE mark in pediatrics; SS Innovations readies smaller instruments

CMR Surgical received the approval for abdominal surgery for its Versius platform in patients under age 18 in Europe, while SS Innovations will incorporate five new instruments into its SSi Mantra system.

By Susan Kelly • Jan. 9, 2026

Teleflex CEO leaving company

Stuart Randle, who retired in 2018, has replaced Liam Kelly as CEO and president on an interim basis.

By Nick Paul Taylor • Jan. 9, 2026

FDA exempts more wearable, AI features from oversight

In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight.

By Elise Reuter • Jan. 8, 2026

4 medtech topics to watch in 2026

From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in 2026.

By Ricky Zipp • Jan. 8, 2026

Surgerii Robotics raises $100M to fund global expansion

The China-based surgical robot manufacturer is gearing up for growth after receiving Europe’s CE mark last year for its single port endoscopic system.

By Susan Kelly • Jan. 7, 2026

J&J submits FDA de novo request for Ottava robot in general surgery

Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft tissue robotic surgery market heats up.

By Susan Kelly • Jan. 7, 2026

Stereotaxis wins FDA approval for robotically navigated ablation catheter

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a J&J catheter.

By Nick Paul Taylor • Jan. 7, 2026